ViewRay™ investment partners include Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, OrbiMed Advisors, and Siemens Venture Capital (SVC) GmbH. Technology partner Siemens AG, Healthcare Sector, collaborates with ViewRay to develop and supply MRI technology for the MRIdian system.
In early 2012, ViewRay closed the final tranche of a $45 million round of Series C venture capital financing to advance the MRIdian system toward commercialization. Siemens Venture Capital led ViewRay’s first round of Series C financing in 2010. ViewRay previously raised $3 million in Series A funding and $25 million in Series B funding.
ViewRay also acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Radiotherapy Guidance Project.
To learn more about investing in ViewRay, contact CFO David Chandler.